Earth Life Sciences
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Earth Life Sciences generated cash of $0, which is more than the previous year. Cash used in financing activities reached the amount of $0 last year.
Cash Flow
| 2013 | 1.54K | 0 | 0 |
|---|---|---|---|
| 2014 | -1.39K | 0 | 0 |
| 2015 | 2.20K | -2.45K | -45K |
| 2016 | 0 | 0 | 0 |
| 2017 | 0 | 0 | 0 |
| 2018 | 0 | 0 | 0 |
| 2019 | -34 | 0 | 34 |
| 2020 | -45.38K | 0 | 45.38K |
| 2021 | -15.86K | 0 | 15.86K |
| 2022 | 0 | 0 | 0 |
CLTS Cash Flow Statement (2013 – 2022)
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 244 | 2.02K | 482 |
Operating activities | ||||||||||
Net income | 0 | -1.58M | -1.82M | -53.77K | -437.99K | -6.78M | -121.63K | -1.36M | -5.00K | -73.14K |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 0 | 0 | 0 | 490 | 490 | 490 | 490 | 490 | 574 | 574 |
Stock-based compensation expense | 0 | 1.51M | 1.78M | 0 | 0 | 6.75M | 0 | 1.30M | 0 | 0 |
| Deferred income tax benefit | 0 | 1.51M | 1.78M | 0 | 0 | 6.75M | 0 | 1.30M | 0 | 0 |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 59.15K | 0 | 0 |
Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 726.66K | 0 | 0 |
Accounts payable | 0 | 27.61K | -5.25K | 53.28K | 37.56K | 0 | 121.14K | -12.90K | 60.04K | 60.04K |
Cash generated by operating activities | 0 | -15.86K | -45.38K | -34 | 0 | 0 | 0 | 2.20K | -1.39K | 1.54K |
Investing activities | ||||||||||
Purchases Of Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Investments In Property Plant And Equipment | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -2.45K | 0 | 0 |
Acquisitions Net | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash generated by investing activities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -2.45K | 0 | 0 |
Financing activities | ||||||||||
Common Stock Issued | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 45K | 0 | 0 |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | 0 | -15.86K | -24.71K | 0 | -62K | 0 | 0 | -45K | 0 | 0 |
Cash used in financing activities | 0 | 15.86K | 45.38K | 34 | 0 | 0 | 0 | -45K | 0 | 0 |
Net Change In Cash | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -130 | -1.74K | 1.54K |
Cash at end of period | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 114 | 283 | 2.02K |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |